Debiopharm Innovation Fund SA
Corporate VC · Lausanne (Switzerland)
Sign up free to access full profile and submit your pitch.
About
Debiopharm Innovation Fund SA, formerly known as Debiopharm Diagnostics S.A. is the venture capital arm of Debiopharm Group specializing in investments at early seed, pre-seed, seed, series A, start-up, early, mid venture and pre commercial stages. The firm seeks to invest in the smart data, oncology, next gen pharma R&D, clinical trial tech, digital medicine, biotechnology, diagnostics, therapeutics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm invests in pre-commercial/commercial companies in the smart data/digital health domain. The firm invests worldwide. The firm invest in pre-seed / seed less than $1 million. The firm invests in series A between $3 million and $5 million. The firm typically invests with a capital participation not exceeding 25 percent in each company and aims at investing into two to three companies per year. The firm seeks minority participation and representation on the Board of Directors of its portfolio companies. The firm makes balance sheet investments. Debiopharm Innovation Fund SA was founded in 2008 and is based in Lausanne, Switzerland.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
